Data is not available at this time.
Lonseal Corporation operates in the construction materials sector, specializing in high-performance plastic products for industrial and commercial applications. The company generates revenue through the manufacture and sale of flooring materials, waterproof sheets, antiviral wall coverings, and PVC films, catering to diverse markets including transportation, semiconductors, and housing. Its product portfolio addresses niche demands such as contamination-proof solutions and sick building syndrome mitigation, positioning it as a specialized supplier in Japan and select international markets. Lonseal’s competitive edge lies in its technical expertise in polymer-based materials, enabling it to serve industries requiring durability, hygiene, and precision. The company’s focus on R&D-driven innovations, such as flexible acrylic films for electronics, reinforces its role as a solutions provider in industrial and infrastructure projects. While domestic sales dominate, its presence in international markets underscores gradual expansion efforts in specialized segments.
Lonseal reported revenue of JPY 21.02 billion for FY2024, with net income of JPY 835 million, reflecting a net margin of approximately 4%. Operating cash flow stood at JPY 1.49 billion, supported by disciplined cost management. Capital expenditures of JPY 451 million indicate moderate reinvestment, aligning with its asset-light manufacturing model. The company’s profitability metrics suggest stable but modest returns in a competitive industrial materials market.
The company’s diluted EPS of JPY 181.21 highlights its ability to convert revenue into shareholder earnings efficiently. With minimal debt (JPY 582 million) and a cash reserve of JPY 7.18 billion, Lonseal maintains a conservative capital structure. Its low beta (0.043) implies resilience to market volatility, though this may also reflect limited growth expectations from investors.
Lonseal’s balance sheet is robust, with cash and equivalents covering total debt 12 times over. The negligible leverage and high liquidity position the company to weather cyclical downturns or invest in incremental growth opportunities. Its asset base is likely weighted toward receivables and inventory, typical for industrial suppliers.
Growth appears steady but unspectacular, with the dividend payout (JPY 70 per share) signaling a commitment to returning capital. The lack of aggressive capex suggests a focus on sustaining current operations rather than expansion. International sales could provide a marginal uplift, but domestic demand remains the primary driver.
At a market cap of JPY 6.86 billion, Lonseal trades at a P/E of ~8.2x, indicating modest valuation multiples typical for niche industrials. The low beta and small-cap status may limit institutional interest, though its dividend yield could appeal to income-focused investors.
Lonseal’s expertise in functional plastic materials and antiviral solutions positions it well for sustained demand in hygiene-sensitive applications. However, its outlook is tempered by reliance on Japan’s construction sector and limited scale. Strategic partnerships or technological breakthroughs in high-value films could unlock incremental growth.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |